Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Halscion
AddedFeb 15, 2024
UpdatedJun 18, 2026
Halscion

Halscion

Series B

Halscion, Inc.: US-based developer of medical devices and biomaterials for wound healing and skin care.

HQ
Duluth, GA, US
Founded
2005
Overview
Compare
Fundraising
Employees

Halscion, Inc. is a US-based developer of medical devices and biomaterials focused on wound healing and skin care. The company manufactures advanced technologies aimed at treating dermatological conditions and improving wound management. Halscion's mission is to enhance patient outcomes through innovative medical solutions.

Halscion has made significant strides in the medical device industry, contributing to better wound care practices. Their products are utilized across various healthcare settings, demonstrating their impact on patient care. The company's advancements in biomaterials have positioned it as a key player in dermatological treatment.

Halscion - Similar Companies

Halcyon Biomedical logo

Halcyon Biomedical

Healionics logo

Healionics

healionics.com

Halo Medical Technologies logo

Halo Medical Technologies

halomedtech.com

Hs Pharmaceuticals logo

Hs Pharmaceuticals

Biofisica logo

Biofisica

biofisica.com

Cresilon logo

Cresilon

cresilon.com

Halsamd logo

Halsamd

Opus KSD logo

Opus KSD

subq-it.com

RenovoDerm logo

RenovoDerm

bTECH logo

bTECH

btechls.com

Brookhaven Medical logo

Brookhaven Medical

Clozex Medical logo

Clozex Medical

clozex.com

Vanson HaloSource logo

Vanson HaloSource

vanson.com

Huxley Medical logo

Huxley Medical

huxleymed.com

Histogen logo

Histogen

histogen.com

Halscion - Quick Facts

Who are Halscion's competitors?

Companies similar to Halscion include Halcyon Biomedical, Healionics, Halo Medical Technologies and Hs Pharmaceuticals.

When was Halscion founded?

Halscion was founded in 2005.

Where is Halscion's headquarters located?

Halscion's headquarters is located in Duluth, GA, US.

How much has Halscion raised to-date?

As of Jul 23, 2016, Halscion has raised a total of $13.8M (USD).

How many employees does Halscion have?

Halscion has 9 employees as of Feb 5, 2024.

Halscion - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Biomaterials
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified